<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02590757</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1917</org_study_id>
    <nct_id>NCT02590757</nct_id>
  </id_info>
  <brief_title>Comparison of NIV-NAVA vs. N-CPAP After Extubation in Preterm Infants Study</brief_title>
  <official_title>Comparison of Non-invasive Ventilation Neurally Adjusted Ventilatory Assist vs. Nasal Continuous Positive Airway Pressure After Extubation in Infants' &lt; 30 Weeks of Gestation: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized controlled study to compare if a a non-invasive neurally adjusted&#xD;
      ventilatory assist (NIV-NAVA) is better than nasal continuous positive airway pressure&#xD;
      (N-CPAP) after extubation in infants' &lt; 30 weeks of gestation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">January 23, 2021</completion_date>
  <primary_completion_date type="Actual">November 13, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Extubation failure</measure>
    <time_frame>extubation - 72 hours</time_frame>
    <description>Failure criteria&#xD;
pH &lt; 7.2 with pCO2 &gt; 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings&#xD;
Severe apnea event requiring bag and mask resuscitation&#xD;
FiO2 &gt;0.6 to maintain SpO2 ≥ 88% after extubation&#xD;
Frequent desaturations (&lt; 85%) ≥ 3/hr not responding to increased ventilatory settings or an increase in Fio2 to 1.0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FiO2 &gt;0.6 to maintain SpO2 ≥ 88% after extubation</measure>
    <time_frame>extubation - 72 hours</time_frame>
    <description>Participants will be followed for the extubation failure within 3 days after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe apnea event requiring bag and mask resuscitation</measure>
    <time_frame>extubation - 72 hours</time_frame>
    <description>Participants will be followed for the extubation failure within 3 days after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FiO2 &gt;0.6 to maintain SpO2 ≥ 88% after extubation</measure>
    <time_frame>extubation - 7 days</time_frame>
    <description>Participants will be followed for the extubation failure within 7 days after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH &lt; 7.2 with pCO2 &gt; 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings</measure>
    <time_frame>extubation - 7 days</time_frame>
    <description>Participants will be followed for the extubation failure within 7 days after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe apnea event requiring bag and mask resuscitation</measure>
    <time_frame>extubation - 7 days</time_frame>
    <description>Participants will be followed for the extubation failure within 7 days after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bronchopulmonary dysplasia</measure>
    <time_frame>postmenstrual age 36 weeks</time_frame>
    <description>Participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of noninvasive ventilation</measure>
    <time_frame>postmenstrual age 40 weeks (until discharge)</time_frame>
    <description>Participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of inspired oxygen supply</measure>
    <time_frame>postmenstrual age 40 weeks (until discharge)</time_frame>
    <description>Participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>postmenstrual age 40 weeks (until discharge)</time_frame>
    <description>Participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>extubation - 3days</time_frame>
    <description>Participants will be followed for 3 days after extubation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>Endotracheal Extubation</condition>
  <condition>Infant, Premature</condition>
  <arm_group>
    <arm_group_label>NIV-NAVA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Noninvasive ventilation in this group is practiced with NIV-NAVA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N-CPAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group will receive nasal continuous positive airway pressure as routinely in neonatal intensive care unit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIV-NAVA</intervention_name>
    <description>Non-invasive neurally adjusted ventilatory assist</description>
    <arm_group_label>NIV-NAVA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>N-CPAP</intervention_name>
    <description>Nasal-continuous positive airway pressure</description>
    <arm_group_label>N-CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  postconceptional age less than 30+0 weeks&#xD;
&#xD;
          -  infants who fulfill the the criteria for extubation for 6 hours extubation criteria:&#xD;
             Ventilator rate ≤ 25 breaths/min, Peak inspiratory pressure (PIP) ≤ 16cmH2O,&#xD;
             Fractional inspired oxygen (FiO2) ≤ 0.3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  conditions which will decrease life expectancy&#xD;
&#xD;
          -  major anomalies which will decrease life expectancy&#xD;
&#xD;
          -  any anomalous conditions which involve upper and lower airway&#xD;
&#xD;
          -  neuromuscular disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han-Suk Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Children's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>October 25, 2015</study_first_submitted>
  <study_first_submitted_qc>October 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2015</study_first_posted>
  <last_update_submitted>July 18, 2021</last_update_submitted>
  <last_update_submitted_qc>July 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han-Suk Kim</investigator_full_name>
    <investigator_title>Professor, Director of Neonatal Intensive Care Unit</investigator_title>
  </responsible_party>
  <keyword>non-invasive ventilation</keyword>
  <keyword>non-invasive neurally adjusted ventilatory assist</keyword>
  <keyword>nasal continuous positive airway pressure</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

